1-7 of 7
Langqi Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-cell RNA-seq uncovers that plerixafor can mobilize more monocyte progenitor cells and enhance the activating graft immune status in multiple myeloma autologous transplantation.

Free
Chenfei Liu, Yuanbin Song, Yang Liang, Jingxia Xu, Lu Lu, Lezong Chen, Chunlei Dai, Tao Chen, Langqi Wang, Yongshuai Jiang, Xianyuan Li, Honghong Yan, Xumiao Zhang, Xiao Zhang, Yinglin Su, Zhenzhen Chou
Journal: Blood
Blood (2025) 146 (Supplement 1): 7698.
https://doi.org/10.1182/blood-2025-7698
Published: 2025
Journal Articles

B-like natural killer cells related to the epstein-barr virus infection present an adaptive immune phenotype and stronger killing activity in lymphomas

Free
Yuanbin Song, Yang Liang, Chenfei Liu, Jingxia Xu, Lu Lu, Pei-Dong Chi, Yiling Song, Hailin Zheng, Lezong Chen, Chunlei Dai, Tao Chen, Langqi Wang, Yongshuai Jiang, Xianyuan Li, Honghong Yan, Xumiao Zhang, Xiao Zhang, Yinglin Su, Zhenzhen Chou, Junqi Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1769.
https://doi.org/10.1182/blood-2025-1769
Published: 2025
Journal Articles

Outcome of bridging therapy in chimeric antigen receptor T cell treatment for Relapsed/Refractory B-cell non-Hodgkin lymphoma: A retrospective study.

Free
Sanfang Tu, Langqi Wang, Shaojie Wu, Yanjie He, Chaoyang Song, Zhao Liang, Xuan Zhou, Lei Wang, Chunyan Yue, Lijuan Zhou, Jilong Yang, Yuhua Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 8045.
https://doi.org/10.1182/blood-2025-8045
Published: 2025
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy with Dual Targeting of CD19 and CD70 to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Meifang Li, Bo Jin, Langqi Wang, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 3492.
https://doi.org/10.1182/blood-2023-186888
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults

Free
Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Meifang Li, Bo Jin, Langqi Wang, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6884.
https://doi.org/10.1182/blood-2023-186622
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Combined with Zanubrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Langqi Wang, Jilong Yang, Bo Jin, Bo Wang, Lijuan Zhou, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Sanfang Tu, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4841.
https://doi.org/10.1182/blood-2023-186439
Published: 2023
Journal Articles

Safety and Efficacy of Single Cycle Blinatumomab Plus VP Chemotherapy for High Tumor Burden Acute Lymphoblastic Leukemia in Adults

Free
Sanfang Tu, Kecheng Wang, Chaoyang Song, Xuan Zhou, Dan Xiong, Guinian Huang, Jia Feng, Jilong Yang, Bo Jin, Bo Wang, Langqi Wang, Yaqi Zhuo, Huifang Chen, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 5818.
https://doi.org/10.1182/blood-2023-184746
Published: 2023